Pharma Journalist -

OSE Immunotherapeutics SA and Servier announced the execution of an amendment to the two-step global licensing option agreement for exclusive global rights to interleukin-7 receptor…
Read More...

Regeneron Pharmaceuticals, Inc. announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that can be administered as prophylaxis before…
Read More...

Celltex Therapeutics Corporation, a Houston, Texas-based biotechnology company founded in 2011 and focused on spearheading breakthroughs in regenerative medicine using adult, autologous…
Read More...

Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to baricitinib for the treatment of…
Read More...

Aurinia Pharmaceuticals Inc. announced that the Company has initiated a Rolling Submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for…
Read More...

Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Medicine, an artificial intelligence company developing end-to-end drug…
Read More...

AcelRx Pharmaceuticals announced the execution of a definitive merger agreement to acquire Tetraphase Pharmaceuticals, Inc. (Tetraphase) in a stock for stock deal at an exchange ratio…
Read More...

Regeneron Pharmaceuticals and Sanofi announced they have started a clinical program evaluating Kevzara (sarilumab) in patients hospitalized with severe COVID-19 infection. Kevzara is a…
Read More...

XORTX Therapeutics Inc. a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late stage clinical programs, announces that it…
Read More...

BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. announced the buildout of a brand new R&D lab. Situated in the Company's 6,100 sq. Ft.,…
Read More...